In colorectal carcinoma, WDR76 could degrade pan-RAS and inhibit cancer stem cell activation, as well as the progression of colorectal carcinoma cell cycle by degrading KRAS, thereby damaging the tumor development. This evidence concerns the gene KRAS and neoplasm.